Clinical Trial Update: Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB [Phase 2]

View source ↗

Summary

Completed Phase 2 study evaluating the early use of erythropoietin and its relationship to markers of cardiac ischemia in patients undergoing cardiopulmonary by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Myocardial Ischemia | Phase 2 | Status: COMPLETED